The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Leukaphereis Product Market Research Report 2024
Synopsis
Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets.
The global Leukaphereis Product market was valued at US$ 825 million in 2023 and is anticipated to reach US$ 1485.3 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
North American market for Leukaphereis Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Leukaphereis Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Leukaphereis Product in Research Applications is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Leukaphereis Product include Asahi Kasei Medical, Fresenius, Haemonetics, Terumo BCT, Macopharma, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology, MEDICA and PuriBlood Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Leukaphereis Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukaphereis Product.
Report Scope
The Leukaphereis Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leukaphereis Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukaphereis Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Medical
Fresenius
Haemonetics
Terumo BCT
Macopharma
Miltenyi Biotec
Guangzhou Daji Medical Science and Technology
MEDICA
PuriBlood Medical
Charles River Laboratories
AllCells
StemExpress
Segment by Type
Leukapheresis Disposables
Leukapheresis Devices
Segment by Application
Research Applications
Therapeutic Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukaphereis Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets.
The global Leukaphereis Product market was valued at US$ 825 million in 2023 and is anticipated to reach US$ 1485.3 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
North American market for Leukaphereis Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Leukaphereis Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Leukaphereis Product in Research Applications is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Leukaphereis Product include Asahi Kasei Medical, Fresenius, Haemonetics, Terumo BCT, Macopharma, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology, MEDICA and PuriBlood Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Leukaphereis Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukaphereis Product.
Report Scope
The Leukaphereis Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leukaphereis Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukaphereis Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Medical
Fresenius
Haemonetics
Terumo BCT
Macopharma
Miltenyi Biotec
Guangzhou Daji Medical Science and Technology
MEDICA
PuriBlood Medical
Charles River Laboratories
AllCells
StemExpress
Segment by Type
Leukapheresis Disposables
Leukapheresis Devices
Segment by Application
Research Applications
Therapeutic Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukaphereis Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukaphereis Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Leukapheresis Disposables
1.2.3 Leukapheresis Devices
1.3 Market by Application
1.3.1 Global Leukaphereis Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Applications
1.3.3 Therapeutic Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukaphereis Product Market Perspective (2019-2030)
2.2 Leukaphereis Product Growth Trends by Region
2.2.1 Global Leukaphereis Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Leukaphereis Product Historic Market Size by Region (2019-2024)
2.2.3 Leukaphereis Product Forecasted Market Size by Region (2025-2030)
2.3 Leukaphereis Product Market Dynamics
2.3.1 Leukaphereis Product Industry Trends
2.3.2 Leukaphereis Product Market Drivers
2.3.3 Leukaphereis Product Market Challenges
2.3.4 Leukaphereis Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukaphereis Product Players by Revenue
3.1.1 Global Top Leukaphereis Product Players by Revenue (2019-2024)
3.1.2 Global Leukaphereis Product Revenue Market Share by Players (2019-2024)
3.2 Global Leukaphereis Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leukaphereis Product Revenue
3.4 Global Leukaphereis Product Market Concentration Ratio
3.4.1 Global Leukaphereis Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukaphereis Product Revenue in 2023
3.5 Leukaphereis Product Key Players Head office and Area Served
3.6 Key Players Leukaphereis Product Product Solution and Service
3.7 Date of Enter into Leukaphereis Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukaphereis Product Breakdown Data by Type
4.1 Global Leukaphereis Product Historic Market Size by Type (2019-2024)
4.2 Global Leukaphereis Product Forecasted Market Size by Type (2025-2030)
5 Leukaphereis Product Breakdown Data by Application
5.1 Global Leukaphereis Product Historic Market Size by Application (2019-2024)
5.2 Global Leukaphereis Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Leukaphereis Product Market Size (2019-2030)
6.2 North America Leukaphereis Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Leukaphereis Product Market Size by Country (2019-2024)
6.4 North America Leukaphereis Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukaphereis Product Market Size (2019-2030)
7.2 Europe Leukaphereis Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Leukaphereis Product Market Size by Country (2019-2024)
7.4 Europe Leukaphereis Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukaphereis Product Market Size (2019-2030)
8.2 Asia-Pacific Leukaphereis Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Leukaphereis Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Leukaphereis Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukaphereis Product Market Size (2019-2030)
9.2 Latin America Leukaphereis Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Leukaphereis Product Market Size by Country (2019-2024)
9.4 Latin America Leukaphereis Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukaphereis Product Market Size (2019-2030)
10.2 Middle East & Africa Leukaphereis Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Leukaphereis Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Leukaphereis Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Asahi Kasei Medical
11.1.1 Asahi Kasei Medical Company Detail
11.1.2 Asahi Kasei Medical Business Overview
11.1.3 Asahi Kasei Medical Leukaphereis Product Introduction
11.1.4 Asahi Kasei Medical Revenue in Leukaphereis Product Business (2019-2024)
11.1.5 Asahi Kasei Medical Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Detail
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Leukaphereis Product Introduction
11.2.4 Fresenius Revenue in Leukaphereis Product Business (2019-2024)
11.2.5 Fresenius Recent Development
11.3 Haemonetics
11.3.1 Haemonetics Company Detail
11.3.2 Haemonetics Business Overview
11.3.3 Haemonetics Leukaphereis Product Introduction
11.3.4 Haemonetics Revenue in Leukaphereis Product Business (2019-2024)
11.3.5 Haemonetics Recent Development
11.4 Terumo BCT
11.4.1 Terumo BCT Company Detail
11.4.2 Terumo BCT Business Overview
11.4.3 Terumo BCT Leukaphereis Product Introduction
11.4.4 Terumo BCT Revenue in Leukaphereis Product Business (2019-2024)
11.4.5 Terumo BCT Recent Development
11.5 Macopharma
11.5.1 Macopharma Company Detail
11.5.2 Macopharma Business Overview
11.5.3 Macopharma Leukaphereis Product Introduction
11.5.4 Macopharma Revenue in Leukaphereis Product Business (2019-2024)
11.5.5 Macopharma Recent Development
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Detail
11.6.2 Miltenyi Biotec Business Overview
11.6.3 Miltenyi Biotec Leukaphereis Product Introduction
11.6.4 Miltenyi Biotec Revenue in Leukaphereis Product Business (2019-2024)
11.6.5 Miltenyi Biotec Recent Development
11.7 Guangzhou Daji Medical Science and Technology
11.7.1 Guangzhou Daji Medical Science and Technology Company Detail
11.7.2 Guangzhou Daji Medical Science and Technology Business Overview
11.7.3 Guangzhou Daji Medical Science and Technology Leukaphereis Product Introduction
11.7.4 Guangzhou Daji Medical Science and Technology Revenue in Leukaphereis Product Business (2019-2024)
11.7.5 Guangzhou Daji Medical Science and Technology Recent Development
11.8 MEDICA
11.8.1 MEDICA Company Detail
11.8.2 MEDICA Business Overview
11.8.3 MEDICA Leukaphereis Product Introduction
11.8.4 MEDICA Revenue in Leukaphereis Product Business (2019-2024)
11.8.5 MEDICA Recent Development
11.9 PuriBlood Medical
11.9.1 PuriBlood Medical Company Detail
11.9.2 PuriBlood Medical Business Overview
11.9.3 PuriBlood Medical Leukaphereis Product Introduction
11.9.4 PuriBlood Medical Revenue in Leukaphereis Product Business (2019-2024)
11.9.5 PuriBlood Medical Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Detail
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories Leukaphereis Product Introduction
11.10.4 Charles River Laboratories Revenue in Leukaphereis Product Business (2019-2024)
11.10.5 Charles River Laboratories Recent Development
11.11 AllCells
11.11.1 AllCells Company Detail
11.11.2 AllCells Business Overview
11.11.3 AllCells Leukaphereis Product Introduction
11.11.4 AllCells Revenue in Leukaphereis Product Business (2019-2024)
11.11.5 AllCells Recent Development
11.12 StemExpress
11.12.1 StemExpress Company Detail
11.12.2 StemExpress Business Overview
11.12.3 StemExpress Leukaphereis Product Introduction
11.12.4 StemExpress Revenue in Leukaphereis Product Business (2019-2024)
11.12.5 StemExpress Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
